Business Context and Reporting Period
This Form 8-K is filed by First Light Acquisition Group, Inc. (not Calidi Biotherapeutics, Inc.) on October 28, 2021. The filing reports a corporate event regarding the trading structure of the Company's securities on the New York Stock Exchange (NYSE).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance metrics.
Material Changes
The primary material change announced is the separation of the Company's Units. Commencing November 1, 2021, holders may elect to trade the components of the Units separately:
- Class A Common Stock: Will trade under the symbol FLAG.
- Redeemable Warrants: Will trade under the symbol FLAGW.
- Units: Units not separated will continue to trade under the symbol FLAGU.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, risk factors, or discussion of contingencies. The document strictly announces the procedural change in trading symbols and the date of implementation.
Investor Verification Checklist
- Verify the effective date of separate trading (November 1, 2021).
- Confirm the correct ticker symbols for the separated components (FLAG and FLAGW) versus the combined Units (FLAGU).
- Note that the registrant is First Light Acquisition Group, Inc., a Special Purpose Acquisition Company (SPAC), not Calidi Biotherapeutics, Inc.
- Review the attached Press Release (Exhibit 99.1) for specific instructions to shareholders regarding the election to separate units.